Eyal Kalo
Directeur Technique/Scientifique/R&D chez ESENSE-LAB LTD
Profil
Eyal Kalo is currently the Director of Research & Development at InnoCan Pharma Corp.
and the Chief Technology Officer at eSense-Lab Ltd.
He holds a doctorate degree from the Weizmann Institute of Science, which was conferred in 2010.
Postes actifs de Eyal Kalo
| Sociétés | Poste | Début |
|---|---|---|
| ESENSE-LAB LTD | Directeur Technique/Scientifique/R&D | - |
| INNOCAN PHARMA CORPORATION | Directeur Technique/Scientifique/R&D | 01/05/2023 |
Formation de Eyal Kalo
| Weizmann Institute of Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INNOCAN PHARMA CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
eSense-Lab Ltd.
 eSense-Lab Ltd. BiotechnologyHealth Technology eSense-Lab Ltd. engages in the research and development of terpene technology. It focuses on the creation of virtual plants through the reverse engineering of plants, and reconstruction of their essence using alternate natural products. It also specializes in the commercialization of the phytochemical profiling of plants, and combines genetics, messenger RNA (mRNA), protein expression, and phytochemical profiles to generate a model of targeted plants. The company was founded on April 13, 2016 and is headquartered in Ness Ziona, Israel. | Health Technology |
